Skip to main content
. 2023 Jul 18;16(7):1021. doi: 10.3390/ph16071021
CELL LINE DISEASE/TYPE
BAF3/P210 Human chronic myeloid leukemia
BAF3/P210T315L Human chronic myeloid leukemia
C91-PL Human T-lymphotropic virus 1
CEM Human acute T-lymphoblastic leukemia
HEL Human acute myeloid leukemia
HL60 Human acute myeloid leukemia
HPB-ALL Human acute T-lymphoblastic leukemia
HS-SULTAN Burkitt’s lymphoma cells
HUT-102 Lymphoma
IMP9 Human malignant B-cells
JURKAT Humana acute T-cell leukemia
K562 Human chronic myeloid leukemia
K652R Human chronic myeloid leukemia resistant
KASUMI Human acute myeloblastic leukemia
KCL-22 Chronic myeloid leukemia
KG1 Human acute myelogenous leukemia
L1210 Mouse lymphocytic leukemia
MOLT 4B Human lymphoid leukemia
NALM6 Human acute lymphoblast leukemia
NB4 Human promyelocytic leukemia with PML/RARα
NB4 R1 Human promyelocytic leukemia with PML/RARα resistant to ATRA
NB4 R2 Human promyelocytic leukemia with PML/RARα resistant to ATRA
NIH/3T3 Mouse fibroblast
RAJI Burkitt’s lymphoma cells
RAMOS Burkitt’s lymphoma cells
RPMI-8226 Chronic myeloid leukemia (human B-lymphocyte with plasmacytoma)
THP-1 Human acute monocytic leukemia
U266 Multiple myeloma (human B-lymphocyte with myeloma)
U937 Human acute myeloid leukemia/ Human monocyte leukemia
UF-1 Human promyelocytic leukemia with PML/RARα
V79-4 Chinese hamster lung fibroblast cells
WEHI-3B JCS Mouse myeloid leukemia
Increase
Decrease